Cardiovascular and Metabolic Risk

Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial

  1. Cristina Razquin1,2,3,
  2. Estefanía Toledo1,2,3,
  3. Clary B. Clish4,
  4. Miguel Ruiz-Canela1,2,3,
  5. Courtney Dennis4,
  6. Dolores Corella3,5,
  7. Christopher Papandreou3,6,
  8. Emilio Ros3,7,
  9. Ramon Estruch3,8,
  10. Marta Guasch-Ferré3,6,9,
  11. Enrique Gómez-Gracia3,10,
  12. Montserrat Fitó3,11,
  13. Edward Yu9,
  14. José Lapetra3,12,
  15. Dong Wang9,
  16. Dora Romaguera3,13,
  17. Liming Liang14,15,
  18. Angel Alonso-Gómez3,16,
  19. Amy Deik4,
  20. Mónica Bullo3,6,
  21. Lluis Serra-Majem3,17,
  22. Jordi Salas-Salvadó3,6,
  23. Frank B. Hu9,18 and
  24. Miguel A. Martínez-González1,2,3,9⇑
  1. 1Department of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain
  2. 2IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
  3. 3CIBER Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, Madrid, Spain
  4. 4Broad Institute of MIT and Harvard University, Cambridge, MA
  5. 5Department of Preventive Medicine, University of Valencia, Valencia, Spain
  6. 6Human Nutrition Unit, Faculty of Medicine and Health Sciences, Institut d’Investigació Sanitària Pere Virgili, Rovira i Virgili University, Reus, Spain
  7. 7Lipid Clinic, Department of Endocrinology and Nutrition, Institut d’Investigacions Biomediques August Pi Sunyer (IDI-BAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain
  8. 8Department of Internal Medicine, Institut d’Investigacions Biomediques August Pi Sunyer (IDI-BAPS), Barcelona, Spain
  9. 9Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA
  10. 10Department of Preventive Medicine, University of Malaga, Malaga, Spain
  11. 11Cardiovascular and Nutrition Research Group, Institut de Recerca Hospital del Mar, Barcelona, Spain
  12. 12Research Unit, Department of Family Medicine, Distrito Sanitario Atención Primaria Sevilla, Seville, Spain
  13. 13Instituto de Investigación Sanitaria Illes Balears (IdISBa), University Hospital of Son Espases, Palma de Mallorca, Spain
  14. 14Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA
  15. 15Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA
  16. 16Department of Cardiology, University Hospital of Alava, Vitoria, Spain
  17. 17Research Institute of Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria, and Service of Preventive Medicine, Complejo Hospitalario Universitario Insular Materno Infantil (CHUIMI), Canary Health Service, Las Palmas de Gran Canaria, Spain
  18. 18Channing Division for Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
  1. Corresponding author: Miguel A. Martínez-González, mamartinez{at}unav.es.
Diabetes Care 2018 Dec; 41(12): 2617-2624. https://doi.org/10.2337/dc18-0840

Data supplements

Back to top
View Selected Citations (0)
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Add to Selected Citations

Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial
Cristina Razquin, Estefanía Toledo, Clary B. Clish, Miguel Ruiz-Canela, Courtney Dennis, Dolores Corella, Christopher Papandreou, Emilio Ros, Ramon Estruch, Marta Guasch-Ferré, Enrique Gómez-Gracia, Montserrat Fitó, Edward Yu, José Lapetra, Dong Wang, Dora Romaguera, Liming Liang, Angel Alonso-Gómez, Amy Deik, Mónica Bullo, Lluis Serra-Majem, Jordi Salas-Salvadó, Frank B. Hu, Miguel A. Martínez-González
Diabetes Care Dec 2018, 41 (12) 2617-2624; DOI: 10.2337/dc18-0840
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section